Abbreviations HBV: hepatitis B virus HCV: hepatitis C virus LCMV: lymphocytic choriomeningitis PD-1: programmed cell death-1 PD-L1: programmed death-ligand 1 CTLA-4 (CD152): cytotoxic T-lymphocyte-associated antigen-4 TIM-3: T-cell immunoglobulin domain and mucin domain 3 HCC: hepatocellular carcinoma IFN- : interferon- TNF- : tumor necrosis factor- IL-2: interleukin-2 IL-10: interleukin-10 IL-21: interleukin-21 TGF- : transforming growth factor- Bim: Bcl2-interacting mediator TCR: T-cell receptor PBMC: peripheral blood mononuclear cell Treg: T-regulatory cell NK cell: NK cell APC: antigen-presenting cell DC: dendritic cell KLRG1: killer cell lectin-like receptor subfamily G member 1 PDGF-BB: platelet-derived growth factor-BB NFAT: nuclear factor of activated T cell T-bet: T-box transcription factor Blimp-1: PR domain zinc-finger protein 1 References Li X, Liu X, Tian L, Chen Y
Although various drugs and compounds have been listed that can target the MET channel to alleviate ototoxicity caused by cisplatin or aminoglycosides, most of these compounds, such as d-Tubocurarine, Phenoxybenzamine, and Carvedilol, not only fail to provide ear protection at high concentrations but also enhance ototoxicity, with a narrow effective dose window limiting the practical clinical application of many MET channel blockers
Neurochemical Journal , 14, 314-320
Individual favorable mutations were combined as described in the text via subcloning using a Bam HI restriction site at the amino acid positions P317/D318 in conjunction with the Sac I restriction site
American Diabetes Association 85th Scientific Sessions, ADA Meeting News, June 22, 2025 (Garvey presentation)
Solution: The added HCl (a strong acid) or NaOH (a strong base) will react completely with formate (a weak base) or formic acid (a weak acid), respectively, to give formic acid or formate and water
